Li Taka Pharmaceuticals Limited
About Li Taka Pharmaceuticals Limited
Data last updated:
Li Taka Pharmaceuticals Limited is a public limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24246MH1981PLC024490.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹8.63 Lakh. It was formerly known as Bora Pharmaceuticals Private Limited and Li Taka Chemicals Limited. It is led by directors including Pravinkumar Kantilal Mutha and Suresh Kanayalal Raka.
Its last annual general meeting (AGM) was held on 30 September 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office is at Prema Chambers 156 B Ganesh Peth, Pune, Maharashtra, India – 411002.
As per MCA filings, the company has open charges of ₹1.06 Cr on record. Court records list 38 cases involving the company, including 26 filed by the company and 12 filed against it; 2 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Name history
Li Taka Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Bora Pharmaceuticals Private Limited, and Li Taka Chemicals Limited. The current legal name is Li Taka Pharmaceuticals Limited.
| Company Name | Status |
|---|---|
| Li Taka Pharmaceuticals Limited | Current |
| Bora Pharmaceuticals Private Limited | Previous |
| Li Taka Chemicals Limited | Previous |
Contact details
Li Taka Pharmaceuticals Limited's registered office is in Pune, Maharashtra.
- Registered AddressPrema Chambers 156 B Ganesh Peth, Pune, Maharashtra, India – 411002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Li Taka Pharmaceuticals Limited
FY 2013 filings availableFinancial Statement Summary
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Li Taka Pharmaceuticals Limited, buy the company report.
Board of directors of Li Taka Pharmaceuticals Limited
Li Taka Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravinkumar Kantilal Mutha | Director | 26 Mar 2009 | 17 Years 6 Months | Current |
| Suresh Kanayalal Raka | Director | 26 Mar 2009 | 17 Years 6 Months | Current |
| Cajetan Valerian Dsouza | Director | 01 Mar 2008 | 18 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Aug 2003 | 90086490 | Vishweshwar Sahakari Bank Ltd. | ₹40 Lakh | Open | |
| 23 Sep 1999 | 90085162 | Jana Seva Shahakari Bank Ltd. | ₹5.6 Lakh | Open | |
| 27 May 1999 | 90088194 | Jana Seva Shahakari Bank Ltd. | ₹20 Lakh | Open | |
| 02 Nov 1998 | 90084923 | Jana Seva Shahakari Bank Ltd. | ₹40 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
Li Taka Pharmaceuticals Limited has 38 court cases on record: 26 filed by Li Taka Pharmaceuticals, 12 filed against it. 2 cases are pending and 36 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 19 | 6 | 0 |
| District courts | 18 | 6 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 38)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Company petition | Filed against the company by Care Unipac Pvt. Ltd. | Disposed |
| Bombay High Court | Company petition | Filed by the company against Care Unipac Pvt. Ltd. | Disposed |
| Bombay High Court | Appeal | Filed by the company against Clover Pharmaceuticals P.Ltd. With Li Taka Pharmaceuticals P.Ltd. and 1 other | Disposed |
| Bombay High Court | Company petition | Filed by the company against Clover Pharmaceuticals P.Ltd.With Li Taka Pharmaceuticals Ltd. and 1 other | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Maharashtra State Electricity Board | Pending |
To see the full case history of Li Taka Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Li Taka Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Li Taka Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Li Taka Pharmaceuticals Limited has 19 board changes on record since 1998: 11 appointments and 8 cessations. The latest: Omprakash Pattanayak ceased to be Director on 18 Apr 2024.
14 earlier events are in the company report.
Frequently asked questions
Li Taka Pharmaceuticals is an active public limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 1981 (45+ years old) and is registered under CIN U24246MH1981PLC024490.
Li Taka Pharmaceuticals has 3 current directors:
- Pravinkumar Kantilal Mutha - Director
- Suresh Kanayalal Raka - Director
- Cajetan Valerian Dsouza - Director
The latest financial statements of Li Taka Pharmaceuticals on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 30 September 2013. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Li Taka Pharmaceuticals is U24246MH1981PLC024490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Li Taka Pharmaceuticals has 38 court cases on record: 26 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.
Li Taka Pharmaceuticals was incorporated on 27 May 1981, making it 45+ years old. It is registered with the Registrar of Companies, Pune.
Omprakash Pattanayak ceased to be Director on 18 Apr 2024. Omprakash Pattanayak was appointed as Director on 01 Oct 2011. Swapnil Prakash Raka ceased to be Director on 01 Oct 2011. Li Taka Pharmaceuticals has 19 board changes on record in total.
The registered office of Li Taka Pharmaceuticals is at Prema Chambers 156 B Ganesh Peth, Pune, Maharashtra, India – 411002.
Li Taka Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Li Taka Pharmaceuticals has open charges of ₹1.06 Cr and no satisfied charges on record as per latest MCA filings.